Chiesi Group logo

Head of Expanded Access Programs, Americas, Global Rare Diseases

Chiesi Group

Boston, MAHybridPosted 11 days ago$164,000 - $226,000
Full TimeDirector & AboveMedical AffairsPharmaceutical
Original posting ↗

Summary

The Global Head, Expanded Access Programs – Americas is responsible for the global strategic leadership, governance, and operational oversight of Expanded Access Programs across the United States, Canada, and Latin America, serving as the organization's senior subject matter expert and accountable leader for EAP activities within the region.

Job description

The role is responsible for developing and implementing the EAP strategy for the Americas in alignment with the broader Global Scientific Engagement & Innovation strategy and company priorities. The position provides strategic leadership across the full EAP lifecycle, including program feasibility, design, implementation, governance, operational execution, ongoing oversight, and program closure.

The Global Head will serve as a key strategic partner to senior Medical Affairs leadership and cross-functional stakeholders, including Regulatory, Pharmacovigilance, Quality, Supply Chain, Finance, Legal, Compliance, Clinical Development, Commercial, and other relevant functions.

Responsibilities

  • Lead Expanded Access Program (EAP) strategy for the Americas, aligning with global and Medical Affairs priorities.
  • Provide strategic direction for EAP activities across the U.S., Canada, and Latin America.
  • Serve as the regional EAP subject matter expert and advisor to senior leadership.
  • Establish EAP priorities, governance, operating principles, and strategic objectives.
  • Partner with global leadership to evolve the EAP operating model and strategy.
  • Contribute to portfolio planning, product launches, lifecycle management, and medical strategies impacting patient access.
  • Lead evaluation, development, implementation, and oversight of EAP programs.
  • Assess opportunities based on patient need, regulatory requirements, medical rationale, feasibility, risk, resources, and budget.
  • Ensure appropriate governance and decision-making processes for EAP requests.
  • Oversee program lifecycle management, including issue escalation and resolution.
  • Ensure compliant processes for adverse event reporting, product complaints, and safety-related activities.
  • Serve as the primary EAP partner to Medical Affairs, Regulatory, Pharmacovigilance, Quality, Supply Chain, Finance, Legal, Compliance, Clinical Development, and Commercial teams.
  • Define roles, responsibilities, governance structures, and escalation pathways.
  • Align patient access objectives with regulatory, compliance, quality, supply, and business requirements.
  • Oversee EAP vendors, CROs, specialty pharmacies, distributors, and service providers.
  • Lead vendor selection, contracting, performance management, and issue resolution.
  • Manage Americas EAP budgets and ensure financial compliance.
  • Drive cost efficiency, scalability, and operational effectiveness.
  • Establish and monitor KPIs and communicate performance to leadership.
  • Drive process standardization, automation, and continuous improvement initiatives.
  • Implement innovative approaches to enhance operations and patient access.
  • Leverage cross-country learnings to develop scalable solutions while meeting local requirements.
  • Contribute to global policies, SOPs, governance frameworks, and operating standards.
  • Maintain relationships with healthcare professionals, institutions, patient organizations, and other key stakeholders.
  • Ensure participating sites have required protocols, documentation, and product information.
  • Represent the company in external EAP forums and professional organizations as appropriate.
  • Lead and develop the Americas EAP organization.
  • Establish objectives, accountability, and performance expectations.
  • Build organizational capabilities in Expanded Access, patient access operations, regulatory requirements, and vendor management.
  • Collaborate with global EAP leaders to drive consistency and share best practices.
  • Provide coaching, mentoring, and career development for team members.

Requirements

  • Bachelor's or Master's degree in life sciences, healthcare, pharmacy, medicine, or related discipline required.
  • Significant pharmaceutical, biotechnology, CRO, or healthcare industry experience.
  • Significant leadership experience in Expanded Access, Compassionate Use, Named Patient, or similar patient access programs.
  • Demonstrated experience developing and executing EAP strategy across multiple countries.
  • Strong understanding of U.S. Expanded Access requirements and international patient access frameworks.
  • Demonstrated ability to operate strategically with senior leadership and influence cross-functional stakeholders.
  • Experience managing complex external vendors, contracts, and budgets.
  • Strong understanding of Medical Affairs, Regulatory, Pharmacovigilance, Quality, Legal, and Compliance requirements.
  • Demonstrated experience leading teams and complex programs across multiple geographies.
  • Strong strategic, analytical, communication, negotiation, and project management capabilities.
  • Experience with rare diseases and/or specialty pharmaceutical products preferred.

Benefits

  • Comprehensive healthcare programs
  • Work-life balance initiatives
  • Relocation support
  • Performance bonuses
  • Flexible working arrangements
  • Remote work options
  • Tax assistance services

Company overview

Chiesi Group is a research-oriented international biopharmaceutical company headquartered in Parma, Italy, with over 85 years of experience in the pharmaceutical industry. Founded in 1935 as a family-owned business, Chiesi has grown into a global pharmaceutical group with 31 affiliates worldwide and more than 7,500 employees. The company specializes in developing and marketing innovative therapeutic solutions across three main business areas: respiratory health (AIR), rare diseases (RARE), and specialty care (CARE). Chiesi is particularly recognized for its leadership in respiratory treatments, including inhalers for asthma and COPD, as well as its growing portfolio in rare disease therapies following the acquisition of Amryt Pharma. As a certified B Corporation since 2019 and a Benefit Corporation in Italy, the US, France, and Colombia, Chiesi is committed to sustainable business practices and has set ambitious goals to achieve net-zero greenhouse gas emissions by 2035. The company invests significantly in R&D, allocating over 24% of its revenues to research and development, making it one of the top Italian pharmaceutical companies for R&D investment. With a strong global presence and a focus on patient-centered innovation, Chiesi continues to expand its therapeutic offerings while maintaining its commitment to social and environmental responsibility.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.